van Geel, Nanja http://orcid.org/0000-0002-3249-8195
Hamzavi, Iltefat H.
Pandya, Amit G.
Wolkerstorfer, Albert
Seneschal, Julien
Garg, Amit
Spuls, Phyllis
Terwee, Caroline B.
Mallett, Sue
Speeckaert, Reinhart
Meurant, Jean Marie
Eleftheriadou, Viktoria
Ezzedine, Khaled
Funding for this research was provided by:
Incyte
LEO Pharma
Article History
Received: 2 March 2022
Accepted: 25 June 2022
First Online: 23 July 2022
Declarations
:
: Approval of the Ethics Committee (UZ Gent, Belgium) has been obtained. Registration number (B): B6702020000867.
: Not applicable
: Prof. Dr. N van Geel is an investigator/consultant/advisor for Abbvie, Pfizer, Incyte, Sun Pharma and MSD/Merck.Prof. Dr. Ph.I. Spuls has done consultancies in the past for Sanofi 111017 and AbbVie 041217 (unpaid), receives departmental independent research grants for TREAT NL registry, for which she is Chief Investigator (CI), from pharma companies since December 2019, is involved in performing clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of, e.g., psoriasis and atopic dermatitis, for which financial compensation is paid to the department/hospital.Dr. Garg is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB, and Viela Biosciences, and receives honoraria. Dr Garg receives research grants from AbbVie, UCB and National Psoriasis Foundation. Amit Garg ORCID ID: ExternalRef removedCB Terwee is one of the founders of the COSMIN initiative.Prof. Dr. K Ezzedine is a consultant for Abbvie, VielBio, Incyte, Pfizer and Pierre Fabre.Dr. A Pandya is a consultant for Abbvie, Arcutis, Avita, Chromaderm, Incyte, Pfizer, Viela Bio, Villaris, Immune Tolerance Network, and Twi and holds stock options with Zerigo Health and Tara Medical.Dr. I Hamzavi AbbVie, fees consulting; Clinuvel, principal investigator, research funding to institution; Incyte, principal investigator, research funding, and consultant fees paid personally; Pfizer Inc., principal investigator and consultant; Avita, PI, research funding.